FGF2 and skin squamous cell carcinoma: Therefore, our results indicate that LNMAC plays a crucial role in FGF2‐mediated lymphangiogenesis and lymphatic metastasis, highlighting that LNMAC might be a therapeutic target for LN metastasis in CSCC patients.